New York, NY – January 24, 2018 Kali, Inc. (USOTC: KALY) has proven to be a new hot cannabis stock over the past two months and an upcoming trigger could rocket the current $0.01 PPS up 1000% to a $0.10 PPS.
The company entered the cannabis sector recently acquiring a patented cannabis extraction technology. The technology has been licensed by Puration, Inc. (USOTC: PURA) for the production of CBT infused water sold into the sports nutrition market. Together, KALY and PURA singed a deal to make a private labeled CBD infused water for Generex Biotechnology (OTCQB: GNBT). KALY also introduced its own CBD infused candies under the brand name Hemp4mula. KALY’s greatest and yet unrecognized value is derived from the company’s medical research surrounding the extracts from the patented extraction process.
The acquisition of the patented extraction process and the corresponding contract announcements saw the PPS rocket out of the sub-penny range on trading volume that put it regularly in the top 25 most actively traded stocks on the OTCMarkets. The jump in price and volume resulted in OTCMarkets flagging the stock for potential promotion concerns. However, since the OTCMarkets flag was posted, the company has updated its financial filings bringing them current with OTCMarkets reporting standards for a current information filer. The company has also launched a new website consistent with its new cannabis business plan. Its’ likely that OTCMarkets is reviewing KALY’s updated filings and reviewing the increase in PPS and volume in reaction to the new business plan and acquired assets and that the reviews will lead to a removal of the currently posted flag for potential promotion concerns.
The removal of the flag could be seen as a validation of the company’s legitimate new cannabis business plan and assets and could in turn be a trigger for another PPS run. When considering KALY compared to a company such as Cannabis Science, (USOTC: CBIS) with its negligible revenue, massive losses and delinquent filings, but a $100 million market cap, it is not unreasonable to think KALY’s PPS could run to $0.10 in response to a clean bill of health, patented technology, revenue, and current filings.
Learn more about the company at www.kali-extracts.com.
NextBigTicker.com (NBT)is a third party publisher and news dissemination service provider. NBT is NOT affiliated in any manner with any company mentioned herein. NBT is news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. NBT's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release or opinion of the writer. NBT is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. NBT has not been compensated for this release and HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies' contracts, the companies' liquidity position, the companies' ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur.